Navigation Links
The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
Date:7/9/2008

- Surfing Becomes First Sport To Mitigate the Impact of a Disease

- Surfing Legends Laird Hamilton and Dave Kalama Co-Host Inaugural Gala to Raise Research Funds

HUNTINGTON BEACH, Calif., July 9 /PRNewswire-USNewswire/ -- Amazingly, surfers have unknowingly held a key to prolonging the lifespan and quality of life for people with cystic fibrosis (CF), a fatal genetic disease that causes the body to produce thick, sticky mucus, which clogs the lungs and leads to life-threatening lung infections.

Several years ago, doctors in Australia noticed young surfers with cystic fibrosis had significantly healthier lungs. The doctors determined that inhaling saltwater mist has a powerful effect on rehydrating the lining of the lungs and allowing CF patients to more easily eliminate bacteria-contaminated mucus. This discovery led researchers to develop a hypertonic saline solution, which CF patients around the world now inhale every day. In essence, CF patients now mimic a "surf session" on a daily basis.

More than 70,000 CF patients face a daily battle, enduring hours of daily therapies and treatments to avoid the threat of mucus build-up in the lungs. While average life expectancy has doubled in the past 25 years to age 37 -- due to advances in treatment and care -- funding is still urgently needed to find the miracle drug leading to a cure.

The recent "saltwater" breakthrough treatment has led the Southern California Chapter of the Cystic Fibrosis Foundation to form a "PIPELINE TO A CURE" campaign to raise funds and to bring about global awareness of the unique bond between the sport of surfing and those with cystic fibrosis.

On July 19, 2008, the Cystic Fibrosis Foundation together with honorary co-chairs and surf legends Laird Hamilton and Dave Kalama will host an inaugural gala at the Hyatt Regency Huntington Beach, California, also known as "Surf City."

Title sponsor PacSun and supporting sponsors the Kelly Slater Fo
'/>"/>

SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
2. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
3. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
4. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
5. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
6. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
11. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  MedSpring Urgent Care, an ... clinic at 517 S. Lamar Blvd., Austin, TX ... clinic is located on the southeast corner of Barton Springs ... from 9 a.m. - 9 p.m. daily, including weekends and holidays. ... Texas, Central Austin , Anderson Mill , ...
(Date:7/28/2014)... 28, 2014  TNI BioTech, Inc. (OTCQB: TNIB) ... on the development, marketing and distribution of opioid-related ... proxy materials with the Securities and Exchange Commission ... Shareholders to be held on Thursday, September 4, ... record date for determining those shareholders eligible to ...
(Date:7/28/2014)... BEIJING , July 28, 2014 Concord ... (NYSE: CCM ), a leading specialty hospital ... of radiotherapy and diagnostic imaging centers in ... 2014, its Board of Directors declared a special cash ... American Depositary Share ("ADS")) on the Company,s outstanding ordinary ...
Breaking Medicine Technology:MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3Concord Medical Declares Special Dividend 2
... The Iowa Health Information Technology Regional Extension Center (HITREC) has selected ... record (EHR), practice management and interoperability solution PrimeSuite® , as ... federal Department of Health and Human Services (HHS) REC healthcare ... , ...
... PRINCETON, N.J. , July 12 ... Co., Ltd., has launched AFC Medirepair® with Signum,s ... .  Arazine™ is the first compound from Signum,s ... pipeline of Signal Transduction Modulators (STMs). The DRx ...
Cached Medicine Technology:Iowa Regional Extension Center Selects Greenway EHR Solutions 2Iowa Regional Extension Center Selects Greenway EHR Solutions 3Iowa Regional Extension Center Selects Greenway EHR Solutions 4Iowa Regional Extension Center Selects Greenway EHR Solutions 5Signum Biosciences, Inc. Announces Commercial Launch of Arazine™ 2Signum Biosciences, Inc. Announces Commercial Launch of Arazine™ 3
(Date:7/28/2014)... (July 28, 2014) -- Researchers from The University of Texas ... and other institutions have identified a combination of pills that ... of the drugs sofosbuvir and simeprevir, with or without ribavirin, ... well tolerated by patients, according to the study published today ... conducted in the U.S. , Eric Lawitz, M.D., clinical ...
(Date:7/28/2014)... North America Carotenoids & Antioxidants Market report defines and segments ... and forecast of revenue. This market is estimated to grow ... 2018, at a CAGR of 7.1% from 2013 to 2018. ... & Antioxidants Market report to get an idea of the ... segmentation in the market, and is supported by various tables ...
(Date:7/28/2014)... The Oneida Indian Nation today announced that golf ... PGA TOUR players will be teeing up with four-time ... for the seventh annual Notah Begay III Foundation (NB3F) ... Atunyote® Golf Club on Wednesday, August 27, the star-studded ... Walker, Jonas Blixt, Angel Cabrera and Louis Oosthuizen, in ...
(Date:7/28/2014)... San Jose, CA (PRWEB) July 28, 2014 ... and family life Americans face today, BlogHer, The Center ... up to launch “Make Life Work,” a campaign to ... faced by families across the U.S. The joint initiative ... by Stacy Morrison, Editor-in-Chief, BlogHer; Judith Warner, Senior Fellow, ...
(Date:7/28/2014)... 28, 2014 According to a ... Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology (CVD, ... (Power, Opto-electronic), Application, and Geography-2013-2020", published by MarketsandMarkets, ... CAGR of 12.63% from 2014 to 2020 and ... market data tables and 88 figures spread through ...
Breaking Medicine News(10 mins):Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 2Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 3Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 4Health News:“Make Life Work” Campaign Launches to Address the Needs of Today's Working Families & Promote Realistic Solution 5Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4
... In a case study that illustrates the need for people ... themselves from pets, a woman with numbness in her feet caused ... Jack Russell terrier chewed off part of her slightly infected big ... the Journal of the American Podiatric Medical Association . ...
... -- The drug telaprevir (Incivek) provides a dramatic improvement in ... infection, says an international team of investigators led by Dr. ... Their study, published in today,s edition of the New ... agent for patient use by the U.S. Food and Drug ...
... HealthDay Reporter , WEDNESDAY, June 22 (HealthDay News) -- Silicone-gel ... of women with the devices requiring removal within 10 years ... And "the longer a woman has the implants, the more ... for the Center for Devices and Radiological Health at the ...
... Medical Center (GUMC) have defined, for the first time, three ... sounds such as speech and discovered that they are ... the June 22 issue of the Journal of Neuroscience ... the help of 13 human volunteers who spent time in ...
... , WEDNESDAY, June 22 (HealthDay News) -- Although depression ... giving birth, those who have had an eating disorder or ... the condition, according to a new study. This ... routine part of prenatal care, concluded researchers from the University ...
... WEDNESDAY, June 22 (HealthDay News) -- People who are born ... anxiety and mood disorders due to the impact that city ... emotion and stress, a new international study indicates. The ... of life for city dwellers, according to the researchers. ...
Cached Medicine News:Health News:Cautionary tale for people with diabetes: Dog consumed part of a sleeping patient's toe 2Health News:NEJM study: New drug represents breakthrough in treatment of hepatitis C 2Health News:NEJM study: New drug represents breakthrough in treatment of hepatitis C 3Health News:FDA: Breast Implants Basically Safe, But Won't Last a Lifetime 2Health News:FDA: Breast Implants Basically Safe, But Won't Last a Lifetime 3Health News:Researchers identify components of speech recognition pathway in humans 2Health News:Researchers identify components of speech recognition pathway in humans 3Health News:Eating Disorders May Raise Risk of Depression in Pregnancy 2Health News:City Living Tied to More Anxiety, Mood Disorders 2
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
... The new Finnpipette Focus from Thermo ... with uncompromising performance. Advanced features such ... .01ul fine volume adjustment on microvolumes help ... in single channel pipettes. The new interchangeable ...
... an immunochromatography based one step in vitro ... Opiates and its metabolite in human urine,specimens. ... above a cut-off level of 300 ng/mL,can ... evaluated in the point of care location ...
... test is an immunochromatography based one ... for qualitative determination of Methamphetamine in ... of 1000 ng/mL. This assay has ... of care,location and is for use ...
Medicine Products: